Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis
Surgery for Obesity and Related Diseases · 2024
DOI: 10.1016/j.soard.2024.06.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Surgery for Obesity and Related Diseases, 2024. Verfasst von Laxmi Dongur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery in Galveston, University of Texas Medical Branch, Texas. Electronic address: ladongur@utmb.edu. Hauptthemen laut MEDLINE: Kidney Transplantation, Bariatric Surgery, Neoplasms, Obesity, Morbid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Obesity, a known independent risk factor for developing malignancy. Additionally, renal transplant recipients (RTR) confer a 2- to 4-fold increased risk of overall malignancies with an excess absolute risk of .7% per year. While transplant recipients are at risk for obesity and malignancy, the effect of bariatric surgery (BS) in the posttransplantation setting is not well known. OBJECTIVES: Our study primarily evaluated the impact of BS on cancer incidence in RTR with severe obesity in the posttransplantation setting. Weight loss outcomes were analyzed secondarily. SETTING: University Hospital. METHODS: A retrospective study using TriNetX database was developed to analyze cancer outcomes in RTR with posttransplantation BS versus RTR without BS from 2000 to 2023. After the exclusion process and propensity matching, both cohorts consisted of 153 patients. RESULTS: RTR-BS had a significantly lower incidence of overall cancer and transplant-related cancers (P < .05). No significant difference was identified in cutaneous, gastrointestinal, and reproductive cancers. Percent Excess Weight Loss (%EWL) was significantly lower in RTR-only cohort (11.4%) versus RTR-BS cohort (57.8%) at 5 years. Sleeve gastrectomy (SG) patients (73.19%) had significantly higher %EWL than Roux en-Y gastric bypass (RYGB) patients (49.33%) at 3 years. No difference in cancer incidence was noted between SG and RYGB patients. CONCLUSION: Postrenal transplantation BS had a diminishing effect on overall and transplant-related cancer incidence in RTR with severe obesity. Significant weight loss was also demonstrated with post-renal transplantation BS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery in Galveston, University of Texas Medical Branch, Texas. Electronic address: ladongur@utmb.edu.
- School of Medicine in Galveston, University of Texas Medical Branch, Texas.
- Department of Pharmacology and Toxicology in Galveston, University of Texas medical Branch, Texas.
- Department of Surgery in Galveston, University of Texas Medical Branch, Texas.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Dongur, L., Samman, Y., Golovko, G., Botnar, K., Kueht, M. L., Moffett, J., & Samreen, S. (2024). Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2024.06.010
Vancouver
Dongur L, Samman Y, Golovko G, Botnar K, Kueht ML, Moffett J, et al. Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis. Surgery for Obesity and Related Diseases. 2024. doi:10.1016/j.soard.2024.06.010
BibTeX
@article{Dongur2024,
author = {Dongur, Laxmi and Samman, Yara and Golovko, George and Botnar, Kostiantyn and Kueht, Michael L and Moffett, Jennifer and Samreen, Sarah},
title = {Cancer incidence following bariatric surgery in renal transplant recipients: a retrospective multi-center analysis},
journal = {Surgery for Obesity and Related Diseases},
year = {2024},
doi = {10.1016/j.soard.2024.06.010}
}
EUVIMED